Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429364 · ClinicalTrials.gov registry record · Phase 3
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome
A Phase 3 study, sponsored by Carelon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 608
- Enrollment target
NCT00429364 is a Phase 3 study that has completed, run by Carelon Research. The registered enrollment target is 608 participants.
The verdict
NCT00429364, a Phase 3 study, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 608 participants
- Enrollment target
Study Summary
Marfan syndrome is a hereditary connective tissue disorder. Many individuals with this condition die because of the associated heart and blood vessel abnormalities. This study will compare the effectiveness of two medications, losartan and atenolol, at slowing aortic root enlargement in individuals with Marfan syndrome.
Interventions
- DRUG Atenolol
- DRUG Losartan Potassium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2007-01 |
| Est. Completion | 2014-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429364
The ClinicalTrials.gov registry entry for NCT00429364 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Atenolol is the first listed.
NCT00429364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429364 about?
NCT00429364 is a clinical study titled "Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome". Marfan syndrome is a hereditary connective tissue disorder. Many individuals with this condition die because of the associated heart and blood vessel abnormalities. This study will compare the effectiveness of two medications, losartan and atenolol, at slowing aortic root enlargement in individuals ...
What is the current status of trial NCT00429364?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 608 participants. The study started on 2007-01. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00429364?
The interventions under investigation include: Atenolol (DRUG), Losartan Potassium (DRUG).
Who is sponsoring clinical trial NCT00429364?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.